Table 3.
Detailed clinical patient and follow‐up findings
| No. | Follow‐up (y) | Creatinine at last follow‐up (μmol/l) | GVHD after RT | Death | Ref. | Note |
|---|---|---|---|---|---|---|
| 1 | 26 | 133.0 | N | N | 6 | |
| 2 | 24 | 97.0 | N | N | 12 | Diagnosis of radiation induced pulmonary fibrosis in 2000; lung transplantation in 2011 |
| 3 | 23 | 79.7 | N | N | 13 | HCV cirrhosis (Child‐Pugh A), Diabetes mellitus type 2 |
| 4 | 19 | 106.1 | N | N | 14 | |
| 5 | 13 | NK | N | Y | 14 | Died of unknown cause |
| 6 | 10 | 106.2 | N | N | 14 | |
| 7 | 5 | 68.1 | N | Y | NP | Died of unknown cause, 11 y after RT |
| 8 | 9 | 76,9 | NK | N | NP | |
| 9 | 17 | 80.0 | N | Y | 7 | Died of unknown cause, 20 y after RT |
| 10 | 12 | 79.0 | N | Y | 8 | Died 12 y after RT with functioning transplant kidney, cause of death presumed cardiac |
| 11 | 10 | 131.0 | N | N | 9 | |
| 12 | 10 | 69.9 | N | N | 9 | |
| 13 | 9 | 81.0 | NK | N | 15 | |
| 14 | 6 | 97.2 | N | N | 11 | |
| 15 | 6 | 87.6 | N | N | 16 | Second RT, successful pregnancy 4 y after second renal transplantation |
| 16 | 10 | 80 | Y | N | 17 | HCV cirrhosis (Child‐Pugh A), manifestation of GVHD: cutaneous |
| 17 | 11 | 48.0 | Y | N | 18 | Manifestation of GVHD: cutaneous and musculoskeletal: scleroderma of lower and upper extremity, skin flare, avascular necrosis of knees, hips, shoulders, ankles; diagnosis of squamous cell carcinoma of the palate in 2016, currently in remission |
| 18 | 4 | 99.1 | N | N | 19 | |
| 19 | 1 | 93.8 | N | N | NP | |
| 20 | 22 | 53.0 | Y | N | 24 | Manifestation of GVHD: increase of liver function impairment (first seen after HSCT) |
| 21 | 2 | 106.0 | N | N | NP | |
| 22 | 1 | 96.0 | Y | N | 21 | Manifestation of GVHD: oral mucosa (mild) |